Follitropin

CHEMBL4297955 Phase 4 Одобрено Unknown

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

This is a hormone medication that stimulates the ovaries to produce eggs, used in fertility treatments for women and to support sperm production in men. It mimics the body's natural follicle-stimulating hormone (FSH) to help with reproduction. It is given by injection under medical supervision.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

This is a hormone medication that stimulates the ovaries to produce eggs, used in fertility treatments for women and to support sperm production in men. It mimics the body's natural follicle-stimulating hormone (FSH) to help with reproduction. It is given by injection under medical supervision.

Yes, Follitropin is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297955. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Ищете информацию, доступную для пациентов?

Follitropin на PillFYI

Краткие Данные

Синонимы: 3

Внешние ссылки

ChEMBL CHEMBL4297955

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.